It is anticipated that the compilation of late breaker abstracts is made possible by studies completed after the initial November 15, 2017 abstract submission deadline. They are intended to represent the very latest development in transplantation science. These abstracts will be reviewed in a very finite period by a special review board, and accepted with the same stringent criteria as the Nov 2017 abstract submissions. The review criteria will be at par with the original call for abstracts in Nov 2017, but for late-breaking abstracts there will be a stronger focus on the criteria of "very latest development in the field of transplantation".
TTS Members will receive an email on January 22 asking for their opinion on the location of the 2022 Congress. Keep an eye out for the email!
Date and time: January 19th, 2018 2:00 PM EST (UTC-5 hours)
Topic: Antibody Mediated Rejection in Liver Transplantation Part I - Role of DSA's and Treatment Options
Description: Antibody mediated rejection (AMR) has become one of the hot topics in liver transplantation recently. In this webinar, world known experts in this topic will discuss the immunological, clinical aspects of AMR as well as available treatment options.
|Moderator: Udeme D Ekong, MD, MPH
Associate Professor of Pediatrics (Gastroenterology), Yale University, USA
|Discussant: Laura J. Wozniak, MD
Assistant Clinical Professor of Pediatrics in the Division of Gastroenterology, Hepatology, and Nutrition at UCLA, USA
|Discussant: Jacqueline O'Leary, MD, MPH
Medical Director of Research for the Baylor Simmons TransplantInstitute in Dallas, Texas, USA
|Speaker: Professor Sandy Feng, MD, PhD
Professor of Surgery in Residence Director, Abdominal Transplant Surgery Fellowship University of California San Francisco
Overview: The demand for kidney transplantation continues to rise inexorably as its life-saving and life-enhancing benefits are strongly established. The supply of kidneys remains sorely inadequate both in quantity and, very importantly, quality. These two factors combine to exert tremendous pressure to accomplish transplantation by aggressively utilizing all available deceased donor organs. This webinar will consider donor, recipient, transplant, and other relevant factors, as well as their potential interplay, that enter into the critical decision of whether to transplant or not to transplant.
January 15 - Doctors at the Mayo Clinic have received FDA approval for a platform that can manufacture stem cells by the billions in just days, in contrast to previous methods of making stem cells that took months.
January 15 - For more than 30 frustrating years, doctors have struggled to find a cure for HIV. Now, with the help of stem cell research, they're closer than ever before.
January 15 - Researchers at St. Jude Children's Research Hospital have developed a new gene therapy that creates fully-functioning immune systems in babies diagnosed with severe combined immunodeficiency (SCID), commonly referred to as the "Bubble Boy" disease.
NIH Blog - Obesity involves the complex interplay of diet, lifestyle, genetics, and even the bacteria living in the gut. But there are other less-appreciated factors that are likely involved, and a new NIH-supported study suggests one that you probably never would have imagined: antenna-like sensory projections on brain cells.
DHRS9 Is a Stable Marker of Human Regulatory Macrophages.
Riquelme P, Amodio G, Macedo C, et al.
Transplantation. 2017 ;101(11):2731-2738.
Cellular therapy using human regulatory macrophages (Mregs) to promote immune regulation is under evaluation in early phase clinical trials in kidney transplantation.
In this study, the authors aimed to define a novel positive markers of human Mregs. A series of monoclonal antibodies (mAb) was generated by vaccinating mice with human Mreg lysates. A mAb clone (ASOT1) was found to react strongly with Mregs; immunoprecipitation and MALDI-MS sequencing identified dehydrogenase/reductase 9 (DHRS9) as the antigen. DHRS9 appeared as a promising specific and stable marker of human Mregs discriminating human Mregs from a panel of in vitro- derived macrophages in other polarization states.
TTS is seeking nominations for three Officer positions that will be vacated in 2018: President-Elect, Vice President and Treasurer. In addition, five of the 12 Councilors-at-large will be changing.
The Medawar Prize, named after Society co-founder Sir Peter Medawar, is recognized as the world's highest dedicated award for the most outstanding contributions in the field of transplantation.
The Transplantation Society bestows Honours and Awards to recognize individuals contributing to the field of transplantation through outstanding achievement (for basic scientists, clinicians and in developing countries), and mentorship and training. All members of TTS in good standing are eligible to make nominations and to be nominated for these Awards.
The Women in Transplantation (WIT) Steering Committee have created the Woman Leader in Transplantation Award to recognize a woman who has helped further the field of transplantation through research, policies, leadership, initiatives or other regarded contributions. Also created by the WIT Steering Committee, the Unsung Hero Award will be presented to one woman who has had an extraordinary impact in transplantation through community service, volunteering, mentorship or other community based activity.
The Transplantation Science Committee together with The Transplantation Society and Transplantation are pleased to announce the best manuscripts published by the journal in 2017. Named after two pioneering giants, a selection committee that included editors of Transplantation, The Transplantation Society, in addition to members and chairs of the Transplantation Science Committee will select two winners amongst a very competitive group of publications.
The Transplantation Society
505 Boulevard René-Lévesque Ouest
Montréal, QC, H2Z 1Y7